Critical Appraisal Flashcards

1
Q

Define Validity

A

Is the finding true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define Generalisability

A

Is the finding applicable elsewhere?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 reasons for not being valid

A
Chance (random error)
—- (finding imprecise)
Bias (systematic error)
—- (finding inaccurate) 
Confounding (error of interpretation)
—- (beware, unknown confounders cannot be statistically accounted for)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define
Efficacy
Vs
Effectiveness

A

Efficacy: Shows if something works under ideal conditions
Vs
Effectiveness: shows if something works under normal conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of research Qs:
Pragmatic research
Vs
Explanatory research

A
Pragmatic research
- demonstrates effectiveness 
Vs 
Explanatory research 
- demonstrated efficacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aspects of

Pragmatic research

A

Unselected population
Pt centred outcomes
Does not interfere with clinical practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aspects of

Explanatory research

A

Can it work under ideal conditions
Specific staff/setting/population
Often clinical outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Null hypothesis

Define

A

No difference between active treatment and placebo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

P value

Define

A

Chance null hypothesis is true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type 1 error =

A

False positive (p value)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type 2 error =

A

False negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Statistical significance =
alpha + beta

Define a+b

A

Alpha
- maximum possibility of a false positive (p value)

Beta
- max possibility of false negative
(Determined by sample size)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Power of study =

A

1- beta

Beta = max possibility of a false negative
Usually set to 80-90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Study power is set by

A
  • Level of alpha
  • Sample size
  • The minimum clinical difference you wish to detect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Issue with multiple hypothesis testing:

A

Increases false positive

- only use if there is a clear rationale to the test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Benefit of randomisation

A

Removes confounders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Concealment prevents

A

Allocation bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Blinding prevents

A

Measurement bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Outcome bias

More likely if

A

Soft outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Intention to treat

A

All analysis

Protects against bias

21
Q

Loss to follow up

Assume

A

Patients list are similar to analysed group.
Unless >30% LTFU
Or difference between test and control group

22
Q

Absolute risk =

A

Intervention - control

23
Q

Relative risk =

A

Intervention-control / proportion

24
Q

NNT=

A

1 / absolute risk

25
Cluster randomisation | Issues
Allocation of concealment not possible | Therefore bias introduced
26
Hawthorne effect =
Change due to being monitored
27
Sustainability
What additional resources are required | What negative effects could occur due to intervention being rolled out
28
Generalisability
X
29
Independence of reference standard
X
30
Work up bias
When a different reference standard is used
31
Incorporation bias =
Diagnostic test forms part of reference standard
32
Reliability =
Intraobserver error
33
Effect of prevalence on Sensitivity and specificity PPV NPV
``` Sensitivity and specificity — remains constant PPV -increases with increasing prevalence NPV - decreases with increasing prevalence ```
34
Likelihood ratio =
Value of information added I =no value >10 is diagnostic <0.1 is rule out
35
Forest plot =
Graph for heterogeneity | In a meta analysis
36
Pros and cons | Meta analysis
Increased precision but same accuracy | Does not overcome bias of original data
37
Areas of evaluation | For critical appraisal
Therapy Service organisation Diagnostic test Systematic reviews
38
Write an abstract | OD PICO RACS
Objective Design Population Intervention Comparator Outcome Results Adverse events Conclusions Studies (further)
39
Two main questions that critical appraisal tries to answer
1) is the result valid | 2) is it generalisable
40
Probability estimates of random error include
P value | Confidence intervals
41
Main factor to consider in non randomised data
Confounders
42
Inaccurate Vs Imprecise Estimates
Inaccurate - due to bias Vs Imprecise - random error
43
Confidence intervals and Precision Wide Vs Narrow
Wide - imprecise Vs Narrow - precise
44
Statistics used to estimate effect of random error on results 2 types
P value - for hypothesis testing Confidence intervals - for estimation of differences between groups
45
P values and alpha values | And associations with false/true positive/negative
P value = probability of false positive (type 1 error) Alpha value = probability of a true positive (Max probability of false positive) Beta value = probability of false negative
46
Allocation or selection bias How it occurs And prevention
If patients or researchers can choose which treatment they get Prevent via randomisation and concealment of allocation
47
How to randomise service organisation as a intervention
Cluster randomisation | Disadvantage - no concealment if allocation
48
80/20 rule | As a chart
Pareto chart Bar chart with cumulative line as percentage
49
Likelihood ratio
The Likelihood Ratio (LR) is the likelihood that a given test result would be expected in a patient with the target disorder compared to the likelihood that that same result would be expected in a patient without the target disorder.